CVVT Showcases Cutting-Edge Innovations at BIOHK2025

Join the Centre for Virology, Vaccinology, and Therapeutics (CVVT) as we unveil cutting-edge advancements in influenza vaccines, liver cancer therapeutics, and respiratory organoids at BIOHK2025. Collaborating with our startup ventures, Hong Kong Universal Biologicals Company Limited (HKUBio) for vaccines, Orimmune BioTech Limited for cancer therapeutics, and BiomOrgan Limited for organoids, we invite you to explore the future of healthcare at 3E-D09 from 10-13 September at the Hong Kong Convention and Exhibition Centre (HKCEC) Hall 3DE to witness the future of healthcare unfold before your eyes.

Exploring Innovations:

• Influenza Vaccine Platform: CVVT presents an influenza-based viral vector nasal spray vaccine platform, revolutionizing the approach to infectious disease prevention and control. Dive into the world of advanced vaccine technology designed to combat respiratory viruses effectively.

  
  

• Liver Cancer Therapeutics: Discover a novel antibody developed by CVVT for the treatment of hepatocellular carcinoma (HCC), a prevalent form of liver cancer. Explore how this innovative therapeutic approach is reshaping the landscape of liver cancer treatment with its potential for improved outcomes and patient care.

  
  

• Respiratory Organoids: Step into the realm of respiratory organoids, where CVVT is pioneering research in developing advanced models of the human respiratory system. Witness the potential of respiratory organoids for disease modeling, drug discovery, and personalized medicine, offering insights into respiratory health and therapeutic interventions.

We invite you to embark on a journey of discovery and innovation with CVVT at BIOHK2025. Whether you are a healthcare professional, researcher, industry enthusiast, or simply curious about the future of medicine, our booth promises an enlightening and enriching experience.

We look forward to welcoming you to BIOHK2025!